Medical technology company Nexstim Oy completed its EUR 8 million financing round successfully. New investors, lead by HealthCap, include the European company LSP (Life Sciences Partners) and Finnish Industry Investment Ltd. The Finnish National Fund for Research and Development Sitra, an existing investor, also participated in the round.
Nexstim develops and commercialises new types of brain diagnosis and therapy technologies. The substantial investment will enable Nexstim to accelerate its international sales and marketing activities in the extensive market for clinical applications.
- Jukka-Pekka Särkkä, Managing Director, Nexstim Ltd,
tel. +358 09 2727 1715 and +358 40 538 9593, jukka-pekka.sarkka(at)nexstim.com